AstraZeneca’s COVID-19 vaccine was first approved in Canada in Feb. 2021, and authorization for it was cancelled in Dec. 2023 ...

As of April 28, national data shows that KP.2 accounted for 26.6 per cent of all COVID-19 cases in Canada, surpassing other JN.1 subvariants. “The nomenclature KP.2. really throws people for a ...

That's a move that would set Alberta apart from the rest of Canada. Currently, Alberta Health's COVID information website ... to get the widely available Pfizer or Moderna inoculations, choosing ...

The Japanese government is set to destroy 77 percent of the COVID-19 oral medications it purchased during the novel ...

Sales of Spikevax, the Cambridge company’s only marketed product, plummeted to $167 million from $1.9 billion, the firm ...

A new family of COVID-19 subvariants dubbed the "FLiRT" variants is spreading in Canada. Despite the playful nickname, these genetic cousins of the Omicron subvariant JN.1 are becoming the dominant ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Pfizer aims to recapture some of the goodwill it gained from rolling out its best-selling Covid-19 ...

Journal Editorial Report: The week's best and worst from Kim Strassel, Allysia Finley, Mary O'Grady and Dan Henninger. Image: Chris Pizzello/Associated Press Canadian opposition leader Pierre ...

Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac ... damaged and paralyzed from Covid vaccines - as they say they ...

Pfizer's stock has experienced significant fluctuations in ... As you know, our business continues to be negatively impacted by a declining COVID environment on a global basis. To that end, we expect ...

Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing ... in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's ...